Gryphon Investors
PE · San Francisco, CA · United States
Stages
Investment region
Industries
Profile
Gryphon Investors is a private equity firm based in San Francisco, established in 1995 by David Andrews. It operates with a team of over 60 investment professionals and 15 dedicated operating partners. The firm emphasizes a collaborative and inclusive approach, integrating investment expertise with operational leadership to foster growth in its portfolio companies. This differentiated approach serves the needs of middle-market management teams effectively. Gryphon specializes in investing in lower-middle-market companies across various sectors including business services, consumer products, healthcare, industrial growth, and technology solutions. The firm typically engages in control equity investments, focusing on stages from Series A to late-stage financing. With over $10 billion in assets under management, Gryphon's investment strategies include the Flagship, Heritage, and Junior Capital funds. The firm is supported by a diverse group of limited partners, including US and international pension plans and family offices. Notable portfolio companies under Gryphon Investors' management include Aqua Dermatology – healthcare services, Kano Laboratories – consumer products, Milani – cosmetics, and Vessco Water – water management solutions. Gryphon's commitment to building market leaders with enduring competitive advantages has been highlighted through numerous platform investments and add-on acquisitions.
Contacts (6)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Capital Provider - Equity Group Managing Fund | — | |||
| Co-CEO & Co-CIO | — | — | — | |
| Capital Provider - Equity Group Managing Fund | — | — | ||
| Founder & Co-CEO | — | — | — | |
| Capital Provider - Equity Group Managing Fund | — | — | ||
| Director | — |
Name, email and phone are partially hidden. Subscribe to see them in full.